Literature DB >> 24975902

Epidemiology of heart failure with preserved ejection fraction.

Charlotte Andersson1, Ramachandran S Vasan2.   

Abstract

Heart failure with preserved ejection fraction (HFPEF) is a common condition, and the prevalence is projected to increase further. Studies differ in the reported incidence and mortality associated with this condition, although there is agreement that between a third and one-half of all patients with heart failure have HFPEF. Although several consensus statements and guidelines have been published, some recent randomized clinical trials have reported low mortality, raising doubts about whether all patients diagnosed with HFPEF have HFPEF or whether the condition is heterogeneous in its cause and prognosis. The overall reported prognosis of patients with HFPEF remains poor.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Heart failure; Mortality; Preserved ejection fraction; Prognosis

Mesh:

Year:  2014        PMID: 24975902      PMCID: PMC4084609          DOI: 10.1016/j.hfc.2014.04.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  72 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

2.  Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Authors:  Frank P Brouwers; Rudolf A de Boer; Pim van der Harst; Adriaan A Voors; Ron T Gansevoort; Stephan J Bakker; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Eur Heart J       Date:  2013-03-06       Impact factor: 29.983

3.  Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

Review 4.  How do patients with heart failure with preserved ejection fraction die?

Authors:  Michelle M Y Chan; Carolyn S P Lam
Journal:  Eur J Heart Fail       Date:  2013-04-21       Impact factor: 15.534

5.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

6.  Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.

Authors:  Marc Klapholz; Matthew Maurer; April M Lowe; Frank Messineo; Jay S Meisner; Judith Mitchell; Jill Kalman; Robert A Phillips; Richard Steingart; Edward J Brown; Robert Berkowitz; Robert Moskowitz; Anita Soni; Donna Mancini; Rachel Bijou; Khashayar Sehhat; Nikita Varshneya; Marrick Kukin; Stuart D Katz; Lynn A Sleeper; Thierry H Le Jemtel
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

7.  Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.

Authors:  Daniel H Katz; Lauren Beussink; Andrew J Sauer; Benjamin H Freed; Michael A Burke; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2013-06-28       Impact factor: 2.778

Review 8.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis.

Authors:  Karen Hogg; Karl Swedberg; John McMurray
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

Review 9.  Biomarkers of heart failure with normal ejection fraction: a systematic review.

Authors:  Jin M Cheng; K Martijn Akkerhuis; Linda C Battes; Laura C van Vark; Hans L Hillege; Walter J Paulus; Eric Boersma; Isabella Kardys
Journal:  Eur J Heart Fail       Date:  2013-07-11       Impact factor: 15.534

10.  Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.

Authors:  Amil M Shah; Sanjiv J Shah; Inder S Anand; Nancy K Sweitzer; Eileen O'Meara; John F Heitner; George Sopko; Guichu Li; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2013-11-18       Impact factor: 8.790

View more
  28 in total

1.  Sex Differences in the Cardiac Effects of Early-Onset Hypertension.

Authors:  Teemu J Niiranen; Karri Suvila; Nissi Suppogu; Joseph E Ebinger; Joao A C Lima; C Noel Bairey Merz; Susan Cheng
Journal:  Hypertension       Date:  2019-09-30       Impact factor: 10.190

2.  Body mass index and heart failure among patients with type 2 diabetes mellitus.

Authors:  Weiqin Li; Peter T Katzmarzyk; Ronald Horswell; Yonggang Zhang; Yujie Wang; Jolene Johnson; Gang Hu
Journal:  Circ Heart Fail       Date:  2015-02-13       Impact factor: 8.790

3.  The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.

Authors:  Lydia E Matesic; Lisa A Freeburg; Laura B Snyder; Lauren-Ashley Duncan; Amber Moore; Paige E Perreault; Kia N Zellars; Edie C Goldsmith; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-21       Impact factor: 4.733

4.  Association between heart failure with preserved ejection fraction and hypertensive retinopathy: more questions than answers!

Authors:  Sunil K Nadar
Journal:  J Hum Hypertens       Date:  2018-04-02       Impact factor: 3.012

Review 5.  Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.

Authors:  Vincenzo B Polsinelli; Sanjiv J Shah
Journal:  Expert Opin Pharmacother       Date:  2017-02-17       Impact factor: 3.889

Review 6.  Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?

Authors:  Sumeet S Mitter; Sanjiv J Shah
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

Review 7.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

Review 8.  Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?".

Authors:  Peter Moritz Becher; Nina Fluschnik; Stefan Blankenberg; Dirk Westermann
Journal:  World J Cardiol       Date:  2015-09-26

Review 9.  Heart Failure in Women--Insights from the Framingham Heart Study.

Authors:  Satish Kenchaiah; Ramachandran S Vasan
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

Review 10.  What is Heart Failure with Mid-range Ejection Fraction? A New Subgroup of Patients with Heart Failure.

Authors:  Sunil K Nadar; Osama Tariq
Journal:  Card Fail Rev       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.